Interní Med. 2018; 20(5): 265-268 | DOI: 10.36290/int.2018.045

One-year experience with a novel antiobesity agent

MUDr. Dita Pichlerová
OB klinika Praha

The novel dual-combination antiobesity agent bupropion/naltrexone was introduced in the Czech Republic in October 2016.Immediately after its introduction to the market, we began to use the drug at the OB clinic. The article summarizes our one-yearexperience with the administration of this novel dual-combination antiobesity agent with central dual action. It was a single-centre,noninterventional, observational study. The efficacy on weight loss and waist circumference reduction as well as toleranceand adverse effects are described.

Keywords: obesity, pharmacotherapy for obesity, adverse effects

Published: December 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pichlerová D. One-year experience with a novel antiobesity agent. Interní Med. 2018;20(5):265-268. doi: 10.36290/int.2018.045.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article


    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.